241 related articles for article (PubMed ID: 9001420)
41. Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32).
Akiyama N; Tsuruta H; Sasaki H; Sakamoto H; Hamaguchi M; Ohmura Y; Seto M; Ueda R; Hirai H; Yazaki Y
Cancer Res; 1994 Jan; 54(2):377-9. PubMed ID: 8275473
[TBL] [Abstract][Full Text] [Related]
42. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.
Arber N; Doki Y; Han EK; Sgambato A; Zhou P; Kim NH; Delohery T; Klein MG; Holt PR; Weinstein IB
Cancer Res; 1997 Apr; 57(8):1569-74. PubMed ID: 9108461
[TBL] [Abstract][Full Text] [Related]
43. Cyclin D1 expression is regulated by the retinoblastoma protein.
Müller H; Lukas J; Schneider A; Warthoe P; Bartek J; Eilers M; Strauss M
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):2945-9. PubMed ID: 8159685
[TBL] [Abstract][Full Text] [Related]
44. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb.
Ezhevsky SA; Nagahara H; Vocero-Akbani AM; Gius DR; Wei MC; Dowdy SF
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10699-704. PubMed ID: 9380698
[TBL] [Abstract][Full Text] [Related]
45. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
[TBL] [Abstract][Full Text] [Related]
46. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
[TBL] [Abstract][Full Text] [Related]
47. Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene.
Jadayel D; Matutes E; Dyer MJ; Brito-Babapulle V; Khohkar MT; Oscier D; Catovsky D
Blood; 1994 Jun; 83(12):3664-71. PubMed ID: 8204891
[TBL] [Abstract][Full Text] [Related]
48. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
49. Characterization of 4 mantle cell lymphoma cell lines.
Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
[TBL] [Abstract][Full Text] [Related]
50. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation.
Seto M; Yamamoto K; Iida S; Akao Y; Utsumi KR; Kubonishi I; Miyoshi I; Ohtsuki T; Yawata Y; Namba M
Oncogene; 1992 Jul; 7(7):1401-6. PubMed ID: 1535701
[TBL] [Abstract][Full Text] [Related]
51. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
Timmermann S; Hinds PW; Münger K
Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
[TBL] [Abstract][Full Text] [Related]
52. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
53. Activin A induction of cell-cycle arrest involves modulation of cyclin D2 and p21CIP1/WAF1 in plasmacytic cells.
Yamato K; Koseki T; Ohguchi M; Kizaki M; Ikeda Y; Nishihara T
Mol Endocrinol; 1997 Jul; 11(8):1044-52. PubMed ID: 9212052
[TBL] [Abstract][Full Text] [Related]
54. Bcl-1/cyclin D1 in malignant lymphoma.
de Boer CJ; van Krieken JH; Schuuring E; Kluin PM
Ann Oncol; 1997; 8 Suppl 2():109-17. PubMed ID: 9209653
[TBL] [Abstract][Full Text] [Related]
55. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Williams ME; Swerdlow SH
Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
[TBL] [Abstract][Full Text] [Related]
56. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H
Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
[TBL] [Abstract][Full Text] [Related]
57. Regulation and function of the cyclin-dependent kinase inhibitor p16CDKN2.
Peters G; Parry D; Hara E; Hall M; Bates S; Palmero I
Leukemia; 1997 Apr; 11 Suppl 3():352-5. PubMed ID: 9209387
[TBL] [Abstract][Full Text] [Related]
58. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
59. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
Kamesaki H; Nishizawa K; Michaud GY; Cossman J; Kiyono T
J Immunol; 1998 Jan; 160(2):770-7. PubMed ID: 9551912
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
